These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33236786)

  • 1. SCN2A-Developmental and Epileptic Encephalopathies: Challenges to trial-readiness for non-seizure outcomes.
    Berg AT; Palac H; Wilkening G; Zelko F; Schust Meyer L
    Epilepsia; 2021 Jan; 62(1):258-268. PubMed ID: 33236786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanded clinical phenotype spectrum correlates with variant function in SCN2A-related disorders.
    Berg AT; Thompson CH; Myers LS; Anderson E; Evans L; Kaiser AJE; Paltell K; Nili AN; DeKeyser JL; Abramova TV; Nesbitt G; Egan SM; Vanoye CG; George AL
    Brain; 2024 Aug; 147(8):2761-2774. PubMed ID: 38651838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare diseases - rare outcomes: Assessing communication abilities for the developmental and epileptic encephalopathies.
    Berg AT; Kaat AJ; Zelko F; Wilkening G
    Epilepsy Behav; 2022 Mar; 128():108586. PubMed ID: 35158285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological concepts in human sodium channel epilepsies and their relevance in clinical practice.
    Brunklaus A; Du J; Steckler F; Ghanty II; Johannesen KM; Fenger CD; Schorge S; Baez-Nieto D; Wang HR; Allen A; Pan JQ; Lerche H; Heyne H; Symonds JD; Zuberi SM; Sanders S; Sheidley BR; Craiu D; Olson HE; Weckhuysen S; DeJonge P; Helbig I; Van Esch H; Busa T; Milh M; Isidor B; Depienne C; Poduri A; Campbell AJ; Dimidschstein J; Møller RS; Lal D
    Epilepsia; 2020 Mar; 61(3):387-399. PubMed ID: 32090326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal assessment of adaptive behavior in infants and young children with newly diagnosed epilepsy: influences of etiology, syndrome, and seizure control.
    Berg AT; Smith SN; Frobish D; Beckerman B; Levy SR; Testa FM; Shinnar S
    Pediatrics; 2004 Sep; 114(3):645-50. PubMed ID: 15342834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The phenotype and treatment of SCN2A-related developmental and epileptic encephalopathy.
    Kim HJ; Yang D; Kim SH; Kim B; Kim HD; Lee JS; Choi JR; Lee ST; Kang HC
    Epileptic Disord; 2020 Oct; 22(5):563-570. PubMed ID: 33000761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders.
    Wolff M; Johannesen KM; Hedrich UBS; Masnada S; Rubboli G; Gardella E; Lesca G; Ville D; Milh M; Villard L; Afenjar A; Chantot-Bastaraud S; Mignot C; Lardennois C; Nava C; Schwarz N; Gérard M; Perrin L; Doummar D; Auvin S; Miranda MJ; Hempel M; Brilstra E; Knoers N; Verbeek N; van Kempen M; Braun KP; Mancini G; Biskup S; Hörtnagel K; Döcker M; Bast T; Loddenkemper T; Wong-Kisiel L; Baumeister FM; Fazeli W; Striano P; Dilena R; Fontana E; Zara F; Kurlemann G; Klepper J; Thoene JG; Arndt DH; Deconinck N; Schmitt-Mechelke T; Maier O; Muhle H; Wical B; Finetti C; Brückner R; Pietz J; Golla G; Jillella D; Linnet KM; Charles P; Moog U; Õiglane-Shlik E; Mantovani JF; Park K; Deprez M; Lederer D; Mary S; Scalais E; Selim L; Van Coster R; Lagae L; Nikanorova M; Hjalgrim H; Korenke GC; Trivisano M; Specchio N; Ceulemans B; Dorn T; Helbig KL; Hardies K; Stamberger H; de Jonghe P; Weckhuysen S; Lemke JR; Krägeloh-Mann I; Helbig I; Kluger G; Lerche H; Møller RS
    Brain; 2017 May; 140(5):1316-1336. PubMed ID: 28379373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What does better look like in individuals with severe neurodevelopmental impairments? A qualitative descriptive study on SCN2A-related developmental and epileptic encephalopathy.
    Downs J; Ludwig NN; Wojnaroski M; Keeley J; Schust Myers L; Chapman CAT; Hecker J; Conecker G; Berg AT
    Qual Life Res; 2024 Feb; 33(2):519-528. PubMed ID: 38064015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of electrophysiological dysfunction and clinical severity in SCN2A-related epilepsies.
    Lauxmann S; Verbeek NE; Liu Y; Zaichuk M; Müller S; Lemke JR; van Kempen MJA; Lerche H; Hedrich UBS
    Hum Mutat; 2018 Dec; 39(12):1942-1956. PubMed ID: 30144217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further corroboration of distinct functional features in SCN2A variants causing intellectual disability or epileptic phenotypes.
    Begemann A; Acuña MA; Zweier M; Vincent M; Steindl K; Bachmann-Gagescu R; Hackenberg A; Abela L; Plecko B; Kroell-Seger J; Baumer A; Yamakawa K; Inoue Y; Asadollahi R; Sticht H; Zeilhofer HU; Rauch A
    Mol Med; 2019 Feb; 25(1):6. PubMed ID: 30813884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mutations and phenotypes of epilepsy-associated genes in epileptic encephalopathies.
    Zhou P; He N; Zhang JW; Lin ZJ; Wang J; Yan LM; Meng H; Tang B; Li BM; Liu XR; Shi YW; Zhai QX; Yi YH; Liao WP
    Genes Brain Behav; 2018 Nov; 17(8):e12456. PubMed ID: 29314583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring the inch stones for progress: Gross motor function in the developmental and epileptic encephalopathies.
    Berg AT; Kaat AJ; Gaebler-Spira D
    Epilepsy Behav; 2022 Dec; 137(Pt A):108953. PubMed ID: 36368092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The phenotypic spectrum of SCN2A-related epilepsy.
    Reynolds C; King MD; Gorman KM
    Eur J Paediatr Neurol; 2020 Jan; 24():117-122. PubMed ID: 31924505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCN2A encephalopathy: A major cause of epilepsy of infancy with migrating focal seizures.
    Howell KB; McMahon JM; Carvill GL; Tambunan D; Mackay MT; Rodriguez-Casero V; Webster R; Clark D; Freeman JL; Calvert S; Olson HE; Mandelstam S; Poduri A; Mefford HC; Harvey AS; Scheffer IE
    Neurology; 2015 Sep; 85(11):958-66. PubMed ID: 26291284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Core Features in Four Developmental Encephalopathies in the Rett Natural History Study.
    Cutri-French C; Armstrong D; Saby J; Gorman C; Lane J; Fu C; Peters SU; Percy A; Neul JL; Marsh ED
    Ann Neurol; 2020 Aug; 88(2):396-406. PubMed ID: 32472944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic action potential clamp predicts functional separation in mild familial and severe de novo forms of
    Berecki G; Howell KB; Deerasooriya YH; Cilio MR; Oliva MK; Kaplan D; Scheffer IE; Berkovic SF; Petrou S
    Proc Natl Acad Sci U S A; 2018 Jun; 115(24):E5516-E5525. PubMed ID: 29844171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vineland adaptive behavior scales to identify neurodevelopmental problems in children with Congenital Hyperinsulinism (CHI).
    Salomon-Estebanez M; Mohamed Z; Michaelidou M; Collins H; Rigby L; Skae M; Padidela R; Rust S; Dunne M; Cosgrove K; Banerjee I; Nicholson J
    Orphanet J Rare Dis; 2017 May; 12(1):96. PubMed ID: 28532504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phenotype study of SCN2A gene related epilepsy].
    Zeng Q; Zhang YH; Yang XL; Zhang J; Liu AJ; Liu XY; Jiang YW; Wu XR
    Zhonghua Er Ke Za Zhi; 2018 Jul; 56(7):518-523. PubMed ID: 29996185
    [No Abstract]   [Full Text] [Related]  

  • 19. Adaptive behavior in autism: Minimal clinically important differences on the Vineland-II.
    Chatham CH; Taylor KI; Charman T; Liogier D'ardhuy X; Eule E; Fedele A; Hardan AY; Loth E; Murtagh L; Del Valle Rubido M; San Jose Caceres A; Sevigny J; Sikich L; Snyder L; Tillmann JE; Ventola PE; Walton-Bowen KL; Wang PP; Willgoss T; Bolognani F
    Autism Res; 2018 Feb; 11(2):270-283. PubMed ID: 28941213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketogenic diet as a successful early treatment modality for SCN2A mutation.
    Turkdogan D; Thomas G; Demirel B
    Brain Dev; 2019 Apr; 41(4):389-391. PubMed ID: 30415926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.